scholarly journals Ultrasonographic characteristics of morphometric and hemodynamic parameters of the liver and spleen in pediatric patients with chronic viral hepatitis B and C

2021 ◽  
Vol 11 (11) ◽  
pp. 201-206
Author(s):  
Y. Demchyshyn ◽  
I. Nezgoda ◽  
S. Poprotska ◽  
A. Asaulenko

Chronic HBV- and HCV-infection in pediatric patients had already became an important social and medical problem due to increasing of its prevalence, specific latent course of these infections and forming of progression process which leads to development of liver fibrosis, cirrhosis and cancer with specific influence to different indexes which shows us the decreasing of quality of life of those patients. Therefore, it is necessary to study the basic risk factors for liver fibrosis progression and ways of their diagnosis, including non-invasive ultrasound techniques, in pediatric patients with chronic HBV- and HCV-infection, as their modification may improve the influence for prognosis and clinical consequences. This article considers the changes of the main ultrasound parameters of the liver and spleen in pediatric patients with chronic HBV- and HCV-infection and ability to use US Grayscale (Y.Davoudi, 2015) for management of pediatric patients.

2021 ◽  
Vol 11 (3) ◽  
pp. 239-245
Author(s):  
Nadiia Gavryliuk ◽  
Ihor Hospodarskyy ◽  
Oksana Prokopchuk ◽  
Olga Namisniak ◽  
Mykhailo Havrylyuk

One of the biggest problems of modern medicine is the difficulty in early diagnostic and effective treatment of HCV infection due to its wide distribution, latent form and terrible consequences as a formation of liver cirrhosis (CP) and hepatocellular carcinoma (HCC). It is important to mention, that the rate of progression of liver fibrosis. It is an important medical and social problem that the number of patients with NAFLD, overweight and obesity is constantly increases [9]. Due to the high prevalence of NAFLD and CHC, these two pathologies will progress and contribute to the progression of fibrosis, and depending on the genome of the virus and metabolic syndrome. There is a high risk of developing CP and HCC even after achieving a stable virological response.The main aim of our investigation was to assess the stages of fibrosis by using non-invasive methods for patients with overweight and obesity who being treated for HCV infection (with posthepatic fibrosis).


2017 ◽  
Vol 38 ◽  
pp. 83-88 ◽  
Author(s):  
Kalliopi Zachou ◽  
Stella Gabeta ◽  
Zakera Shums ◽  
Nikolaos K. Gatselis ◽  
George K. Koukoulis ◽  
...  

2015 ◽  
Vol 45 (12) ◽  
pp. 1243-1251 ◽  
Author(s):  
Olga H. Orasan ◽  
Mihaela Iancu ◽  
Madalina Sava ◽  
Aniela Saplontai-Pop ◽  
Angela Cozma ◽  
...  

2019 ◽  
Vol 17 (8) ◽  
pp. 44-47
Author(s):  
A. I. Fazulzyanova ◽  
◽  
S. V. Tkacheva ◽  
A. K. Khusainova ◽  
N. F. Gayfutdinov ◽  
...  

2016 ◽  
Vol 19 (3) ◽  
pp. 55-59
Author(s):  
Andreea Rădășan ◽  
◽  
Mihai Voiculescu ◽  
Laura Elena Iliescu ◽  
◽  
...  

Introduction. In recent years there have been major advances in the treatment and prevention of viral hepatitis, but this pathology is still a major health and socio-economic problem. The defining element for this disease is the liver fibrosis, a histological component of particular importance due to its role in the formation of liver lesions of cirrhosis. Thus, an essential step in the management of chronic viral hepatitis is the detection and measurement of liver fibrosis. Today we have invasive methods for detecting liver fibrosis, the liver puncture biopsy, and non-invasive methods, which in turn are divided into serum methods and imaging methods (2). Purpose of the Study. The aim of this study is to determine if transcutaneous elastography (FibroScan) is equally reliable in case of viral hepatitis B, as with viral hepatitis C. Material and Method: The study comprises a total of 1,127 patients with liver disease of HBV and HCV aetiology. These patients were examined using FibroScan in the period July 2009 - April 2011. Results: Of the 1,177 patients investigated using FibroScan, 40 underwent liver biopsy as well. Of these, 82% have obtained same stages of liver fibrosis in these two investigations, and 18% achieved different stages of fibrosis in these two tests. For the patients with HCV infection, we obtained a 67.81% match of the two non-invasive tests, FibroScan and FibroMax, and a 79.16% match of FibroScan compared to the Liver Biopsy. For the B virus, the compliance is even better, of 75% (FibroScan - FibroMax), and 80% for FibroScan - LB. Conclusions: FibroScan is one of the non-invasive assessment methods of liver fibrosis with diagnose accuracy similar to FibroMax and close to Liver Biopsy.


2020 ◽  
Vol 1 (10) ◽  
pp. 4-11
Author(s):  
M. Yu. Galushko ◽  
A. Yu. Ishchenko ◽  
S. A. Pozdniakov ◽  
I. G. Bakulin

Aims: 1. To evaluate the applicability of The Expert Assessment (EA) based on the algorithm developed by the authors in performance assessment of transient elastography by M-probe (TE-M) and XL-probe (TE-XL), Fibrotest® (FT), shear wave elastography (SWE) and liver biopsy (LB) in fibrosis staging in chronic hepatitis C (CHC) patients in an approach without a «gold» standard; 2. To evaluate the quality of the proposed model (EA efficacy) in comparison with the results of the Rasch Model (MR) being an extension of the Latent Variable Analysis.Material and methods. Using the five studied diagnostic methods liver fibrosis staging was performed in chronic hepatitis C patients. Based on the algorithm developed EA was applied to each patient of the cohort and as a result fibrosis stage was established. That fibrosis stage considered a virtual reference. Sensitivity and specificity estimation as well as AUC calculation for studied methods was performed against the reference standard. The quality of the model (EA efficacy) estimated in the Rasch Model (MR) being an extension of the Latent Variable Analysis.Results. 99 patients with reliable results of each of the five diagnostic methods were included into the study. The main characteristics of the cohort were: 59.6% individuals of male gender, average age of 37 years (21–63), median BMI of 25.8 kg / m2. As per the results of the EA in detecting of mild fibrosis (F1), the values of AUC, sensitivity and specificity were, respectively: 0,972; 94,3; 91,3 for TE-M; 0,964; 90,6; 91,3 for TE-XL; 0,806; 81,1; 73,9 for FT; 0,907; 88,7; 71,7 for SWE; 0,832; 92,5; 37,0 for LB. In detecting of moderate fibrosis (F2), the appropriate values were: 0,981; 93,8; 94,0 for TE-M; 0,967; 90,6; 97,0 for TE-XL; 0,873; 75,0; 80,6 for FT; 0,957; 84,4; 91,0 for SWE; 0,937; 90,6; 94,0 for LB. In detecting of significant fibrosis (F3), the corresponding values were: 0,994; 95,5; 96,1 for TE-M; 0,987; 90,9; 97,4 for TE-XL; 0,870; 63,6; 84,4 for FT; 0,961; 86,4; 97,4 for SWE; 0,990; 90,9; 98,7 for LB. In detecting cirrhosis (F4), the appropriate values were: 0,995; 92,3; 97,7 for TE-M; 0,994; 100,0; 98,8 for TE-XL; 0,874; 38,5; 93,0 for FT; 0,996; 92,3; 100,0 for SWE; 0,964; 69,2; 100,0 for LB. The EA was shown to have high degree of consistency (correlation coefficient = 0,923; p <0,05) when compared to the MR.Conclusion. The EA was shown as a highly informative approach, applicable for performance assessment of the diagnostic methods for liver fibrosis staging without using LB as the “gold” standard. Non-invasive methods have demonstrated higher diagnostic characteristics with changing the standard from the traditional (LB) to virtual (EA). The high degree of consistency of the results of EA and MR confirm the high quality of the algorithm developed by the authors.


Sign in / Sign up

Export Citation Format

Share Document